Antares Pharma Inc (ATRS)

Sector:
HEALTH CARE
Industry:
HEALTH CARE SUPPLIES
SIC:
SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
CEO:
Robert F. Apple
Employees:
165
100 PRINCETON SOUTH, SUITE 300, EWING, NJ 08628
609-359-3020

Antares Pharma, Inc. is a specialty pharmaceutical company. It focuses on the development and commercialization of self-administered parenteral pharmaceutical products and technologies. It has one operating segment, drug delivery, which includes the development of injection devices and injection based pharmaceutical products as well as transdermal gel products. The company was founded in 1979 and is headquartered in Ewing, NJ.

Data derived from most recent annual or quarterly report
Market Cap 607.052 Million Shares Outstanding170.042 Million Avg 30-day Volume 641.306 Thousand
P/E Ratio11.5296 Dividend Yield0.0 EPS
Price to Revenue4.5325 Debt to Equity0.325 EBITDA23.299 Million
Price to Book Value5.6952 Operating Margin12.8503 Enterprise Value704.245 Million
Current Ratio1.851 EPS Growth0 Quick Ratio1.367
1 Yr BETA 1.0286 52-week High/Low 5.07 / 3.11 Profit Margin39.312
Operating Cash Flow Growth154.752 Altman Z-Score4.6446 Free Cash Flow to Firm 8.68 Million
View SEC Filings from ATRS instead.

View recent insider trading info

Funds Holding ATRS (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding ATRS BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

VOLKART CARMEN B

  • Director
0 2021-10-27 2

JACOB LEONARD S

  • Director
295,575 2021-08-27 3

GUETH ANTON

  • Director
467,577 2021-07-08 4

APPLE ROBERT F PRESIDENT & CEO

  • Officer
  • Director
5,367,098 2021-06-10 5

ROCHE ROBERT P JR

  • Director
216,359 2021-06-10 1

GRAHAM PETER J EVP GENERAL COUNSEL, SECRETARY

  • Officer
1,390,625 2021-06-10 4

GARRITY THOMAS J

  • Director
298,400 2021-06-10 3

POWELL FRED M EXECUTIVE VICE PRESIDENT & CFO

  • Officer
1,716,474 2021-06-10 4

RICHARDSON PETER C EVP, R&D CHIEF MEDICAL OFFICER

  • Officer
105,236 2021-06-10 3

GREENLEAF PETER

  • Director
128,187 2021-06-10 1

SMITH KAREN L.

  • Director
128,187 2021-06-10 1

SAMSON MARVIN

  • Director
51,751 2020-01-10 0

TURSI JAMES PATRICK EVP, CHIEF MEDICAL OFFICER

  • Officer
45,205 2019-06-13 0

GONELLA JACQUES

  • Director
9,385,848 2019-02-26 0

MUCKENHIRN KEITH E VP/CONTROLLER & INTERIM CFO

  • Officer
50,000 2016-09-04 0

FICKENSCHER JAMES E SENIOR VICE PRESIDENT & CFO

  • Officer
391,266 2016-06-02 0

FLYNN JAMES E

DEERFIELD MGMT L.P.

DEERFIELD MANAGEMENT CO

DEERFIELD PARTNERS, LP

DEERFIELD INTERNATIONAL MASTER FUND, L.P.

DEERFIELD SPECIAL SITUATIONS FUND, L.P.

  • 10% Owner
  • POSSIBLE MEMBER OF 10% GROUPPOSSIBLE MEMBER OF 10% GROUPPOSSIBLE MEMBER OF 10% GROUPPOSSIBLE MEMBER OF 10% GROUPPOSSIBLE MEMBER OF 10% GROUPPOSSIBLE MEMBER OF 10% GROUP
No longer subject to file 2015-09-28 0

FLYNN JAMES E

DEERFIELD MGMT L.P.

DEERFIELD MANAGEMENT CO

DEERFIELD PARTNERS, LP

DEERFIELD INTERNATIONAL MASTER FUND, L.P.

  • 10% Owner
  • POSSIBLE MEMBER OF 10% GROUPPOSSIBLE MEMBER OF 10% GROUPPOSSIBLE MEMBER OF 10% GROUPPOSSIBLE MEMBER OF 10% GROUPPOSSIBLE MEMBER OF 10% GROUP
73,187,835 2015-07-17 0

HOBBS EAMONN P PRESIDENT & CEO

  • Officer
  • Director
435,990 2015-06-22 0

STACEY JENNIFER EVANS SVP, GENERAL COUNSEL & SECTY

  • Officer
92,042 2015-05-28 0

WOTTON PAUL K PRESIDENT AND CEO

  • Officer
  • Director
937,725 2014-05-29 0

DAVE KAUSHIK J EXECUTIVE VICE PRESIDENT

  • Officer
265,028 2013-06-03 0

SADOWSKI PETER L SENIOR VICE PRESIDENT

  • Officer
0 2012-05-17 0

SHROTRIYA RAJESH C

  • Director
177,628 2012-05-17 0

CARRARA DARIO SENIOR VICE PRESIDENT (1)

  • Officer
27,500 2010-12-07 0

STOVER JACK E PRESIDENT AND CEO

  • Officer
  • Director
276,666 2008-05-14 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days
No current insider transactions

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
ANTARES PHARMA INC ATRS 2022-01-17 22:15:04 UTC -0.219 0.289 5100000
ANTARES PHARMA INC ATRS 2022-01-17 21:45:03 UTC -0.219 0.289 5100000
ANTARES PHARMA INC ATRS 2022-01-17 21:15:03 UTC -0.219 0.289 5100000
ANTARES PHARMA INC ATRS 2022-01-17 20:45:03 UTC -0.219 0.289 5100000
ANTARES PHARMA INC ATRS 2022-01-17 20:15:04 UTC -0.219 0.289 5100000
ANTARES PHARMA INC ATRS 2022-01-17 19:45:03 UTC -0.219 0.289 5100000
ANTARES PHARMA INC ATRS 2022-01-17 19:15:03 UTC -0.219 0.289 5100000
ANTARES PHARMA INC ATRS 2022-01-17 18:45:03 UTC -0.219 0.289 5100000
ANTARES PHARMA INC ATRS 2022-01-17 18:15:03 UTC -0.219 0.289 5100000
ANTARES PHARMA INC ATRS 2022-01-17 17:45:03 UTC -0.219 0.289 5100000
ANTARES PHARMA INC ATRS 2022-01-17 17:15:03 UTC -0.219 0.289 5100000
ANTARES PHARMA INC ATRS 2022-01-17 16:45:03 UTC -0.219 0.289 5100000
ANTARES PHARMA INC ATRS 2022-01-17 16:15:04 UTC -0.219 0.289 5100000
ANTARES PHARMA INC ATRS 2022-01-17 15:45:03 UTC -0.219 0.289 5100000
ANTARES PHARMA INC ATRS 2022-01-17 15:15:03 UTC -0.219 0.289 5100000
ANTARES PHARMA INC ATRS 2022-01-17 14:45:03 UTC -0.2091 0.2791 5100000
ANTARES PHARMA INC ATRS 2022-01-17 14:15:03 UTC -0.2091 0.2791 5100000
ANTARES PHARMA INC ATRS 2022-01-17 13:45:03 UTC -0.2091 0.2791 5100000
ANTARES PHARMA INC ATRS 2022-01-17 13:15:03 UTC -0.2091 0.2791 5100000
ANTARES PHARMA INC ATRS 2022-01-17 12:45:03 UTC -0.2091 0.2791 5100000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin

Elevate your investments